by Kristie Auman-Bauer,Pennsylvania State UniversityCredit: AI-generated imageOver 20 percent of older adults suffer from subjective memory impairment, where a person reports having trouble reme
by Kristie Auman-Bauer,Pennsylvania State UniversityCredit: AI-generated imageOver 20 percent of older adults suffer from subjective memory impairment, where a person reports having trouble reme
by Catherine Talbot,The ConversationCredit: AI-generated imageThe approximately850,000people living with dementia in the UK have been badly affected by COVID-19. Many live in care ho
by Catherine Talbot,The ConversationCredit: AI-generated imageThe approximately850,000people living with dementia in the UK have been badly affected by COVID-19. Many live in care ho
by Baylor College of MedicineDr. Jeannie Chin. Credit: Baylor College of MedicineMemory impairment and mood changes are typically observed in patients with Alzheimer's disease but what distur
by Baylor College of MedicineDr. Jeannie Chin. Credit: Baylor College of MedicineMemory impairment and mood changes are typically observed in patients with Alzheimer's disease but what distur
byRegenstrief InstituteCredit: CC0 Public DomainAbout one in three stroke survivors will experience depression in the first year after a stroke. A new study from Regenstrief Institute, Indiana U
byRegenstrief InstituteCredit: CC0 Public DomainAbout one in three stroke survivors will experience depression in the first year after a stroke. A new study from Regenstrief Institute, Indiana U
by Serena Gordon, Healthday Reporter(HealthDay)—Most seniors expect their doctor to recommend testing of thinking and memory when it's needed.But a new survey discovered that is rarely the case: O
by Serena Gordon, Healthday Reporter(HealthDay)—Most seniors expect their doctor to recommend testing of thinking and memory when it's needed.But a new survey discovered that is rarely the case: O
by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i
by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i
by Tokyo Metropolitan UniversitySet up of each condition. Participants were seated in a chair with their left upper limb placed on a table and maintained in a resting position. (a) The Visual-mot
by Tokyo Metropolitan UniversitySet up of each condition. Participants were seated in a chair with their left upper limb placed on a table and maintained in a resting position. (a) The Visual-mot
by King's College LondonCredit: King's College LondonAlzheimer's Disease International (ADI) has published its first report on the impact of dementia in sub-Saharan Africa (SSA), at i
by King's College LondonCredit: King's College LondonAlzheimer's Disease International (ADI) has published its first report on the impact of dementia in sub-Saharan Africa (SSA), at i
by University of SurreyTime course of serum glucose and insulin concentrations during oral glucose tolerance testing in night shift workers at baseline, after 12 weeks, and after 24 weeks as comp
by University of SurreyTime course of serum glucose and insulin concentrations during oral glucose tolerance testing in night shift workers at baseline, after 12 weeks, and after 24 weeks as comp
byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that
byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that
by Stanford UniversityResearchers demonstrated the advantages of the flexible and elastic NeuroString technology by threading a probe through a segment of mouse colon. Credit: Zhenan Bao labImbal
by Stanford UniversityResearchers demonstrated the advantages of the flexible and elastic NeuroString technology by threading a probe through a segment of mouse colon. Credit: Zhenan Bao labImbal